Clinical Trial Update: Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a fixed-dose intervention to enhance survival in patients with serious mental illness, including schizophrenia and related disorders,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Cardiovascular Disease
• Major Depressive Disorder
• Psychosis Nos
• Schizoaffective Disorder
• Schizophrenia
• Serious Mental Illness

Drugs mentioned

• New England Enhancing Survival (NEES) Fixed Dose Intervention

Snippet

Sponsor: Mclean Hospital | Conditions: Serious Mental Illness, Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2022-11-22